Omeros (NASDAQ:OMER) Earns Buy Rating from D. Boral Capital
Omeros (NASDAQ:OMER – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at D. Boral Capital in a research note issued on Friday,Benzinga reports. They currently have a $36.00 price target on the biopharmaceutical company’s stock. D. Boral Capital’s target price indicates a potential upside of 295.60% from the company’s current price. […]
More Stories
The Golden Rule: He Who Has the Gold Makes the Rules
By Rodd Mann “O Gold! I still prefer thee unto paper, which makes bank credit like a bark of vapor.”—Lord...
The Golden Rule: He Who Has the Gold Makes the Rules
By Rodd Mann “O Gold! I still prefer thee unto paper, which makes bank credit like a bark of vapor.”—Lord...
The Golden Rule: He Who Has the Gold Makes the Rules
By Rodd Mann “O Gold! I still prefer thee unto paper, which makes bank credit like a bark of vapor.”—Lord...
Pipeline Projects Prioritized for Quick Approval Under Emergency Energy Orders
By John Haughey More than 220 natural gas pipeline-related proposals across 22 states are among nearly 700 projects that could...
Pipeline Projects Prioritized for Quick Approval Under Emergency Energy Orders
By John Haughey More than 220 natural gas pipeline-related proposals across 22 states are among nearly 700 projects that could...
Pipeline Projects Prioritized for Quick Approval Under Emergency Energy Orders
By John Haughey More than 220 natural gas pipeline-related proposals across 22 states are among nearly 700 projects that could...